Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China

Louie KS, de Sanjose S, Diaz M, et al: Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 100:1191–1197. 2009. View Article : Google Scholar : PubMed/NCBI

Lang J: Problems in connection with diagnosis and treatment of cervical lesions. Zhonghua Fu Chan Ke Za Zhi. 36:261–263. 2001.(In Chinese).

Weinstein LC, Buchanan EM, Hillson C, et al: Screening and prevention: cervical cancer. Prim Care. 36:559–574. 2009. View Article : Google Scholar : PubMed/NCBI

Cuzick J, Arbyn M, Sankaranarayanan R, et al: Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 26(Suppl 10): K29–K41. 2008. View Article : Google Scholar

Cruickshank ME: The role of human papillomavirus in risk management. Rev Gynaecol Practice. 3:292–233. 2003. View Article : Google Scholar

Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI

Pilch H, Günzel S, Schäffer U, et al: The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer. 11:39–48. 2001.

Stevens MP, Garland SM, Tan JH, et al: HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol. 81:1283–1291. 2009. View Article : Google Scholar : PubMed/NCBI

Wu K, Fu Y and Jiang H: Molecular epidemiology analysis of cervical HPV in women of childbearing age in Guangzhou, China. Guangdong Med. 25:386–391. 2004.(In Chinese).

Prandi S, Beccati D, De Aloysio G, et al: Applicability of the Bethesda System 2001 to a public health setting. Cancer. 108:271–276. 2006. View Article : Google Scholar : PubMed/NCBI

de Sanjosé S, Diaz M, Castellsagué X, et al: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 7:453–459. 2007.PubMed/NCBI

Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L and Chauhan SC: High prevalence of human papillomavirus infection in American Indian women of the Northern Plains. Gynecol Oncol. 2:236–241. 2007.(In Chinese).

Li N and Dai M: Human papillomavirus infection in China: a multi-centric cross-sectional study. Chinese Journal of Disease Control and Prevention. 12:411–415. 2008.

Franceschi S, Herrero R, Clifford GM, et al: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 119:2677–2684. 2006. View Article : Google Scholar : PubMed/NCBI

Zeng ZP, Chen F, Liu B, et al: Studies of risk factors of cervical cancers in Yangcheng County, Shanxi Province, China. Tumor Prevention Research. 31:178–181. 2004.

Zhao FH, Ma JF, Qiao YL, et al: Association between high-risk human papillomavirus DNA load and cervical intraepithelial lesion. Zhonghua Liu Xing Bing Xue Za Zhi. 25:921–924. 2004.(In Chinese).

Zhao FH, Forman MR, Belinson J, et al: Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer. 118:442–448. 2006. View Article : Google Scholar : PubMed/NCBI

Deacon JM, Evans CD, Yule R, et al: Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 83:1565–1572. 2000. View Article : Google Scholar